Target intelligence / Profile preview

ZFAND2A divergent transcript (ZFAND2A-DT)

Target
ZFAND2A-DT
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

ZFAND2A divergent transcript (ZFAND2A-DT) is a human long non-coding RNA gene (HGNC:41187, NCBI GeneID: 101927021, Ensembl: ENSG00000229043), transcribed but not protein-coding. As a member of the lncRNA class, ZFAND2A-DT is annotated as a transcript oriented divergently to the ZFAND2A coding gene and may function to regulate the expression of nearby genes, potentially through enhancer and promoter interactions, but no protein product or direct therapeutic applications are known at present. There is no available evidence for its use as a drug target, biomarker, or established involvement in disease. All current evidence indicates that ZFAND2A-DT is an annotated lncRNA, not regarded as a direct therapeutic or pharmacological target.

Other names
ZFAND2A-DTZFAND2A divergent transcriptENSG00000229043NR_110065
02

Biological functions

Regulation of gene expression (by enhancer and promoter interaction)Potential modulation of gene activity in cis or trans

Beyond the preview

Go deeper on ZFAND2A divergent transcript (ZFAND2A-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZFAND2A divergent transcript (ZFAND2A-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call